EUVIMEDEUVIMED entdecken
Crossref

Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months

Yun Jeong Lee iD, Ae Ryoung Kim, Jong-Mok Lee iD, Young Kyu Shim, Jae So Cho, Hye Won Ryu, Soonhak Kwon, Jong-Hee Chae

Muscle & Nerve · 2023

DOI: 10.1002/mus.27950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2023. Verfasst von Yun Jeong Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea. Hauptthemen laut MEDLINE: Caregiver Burden, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Biogen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Novel disease‐modifying approaches for spinal muscular atrophy (SMA) have highlighted the patient's perspective on functional changes over time. In this study, we evaluated the impact of nusinersen on the health‐related quality of life (HRQoL) of patients with later‐onset SMA and the caregiver burden.

Methods

We assessed the changes in HRQoL using the Pediatric Quality of Life Inventory 4.0 Generic Core Scale (PedsQL GCS) and the Pediatric Quality of Life Inventory 3.0 Neuromuscular Module (PedsQL NMM) during 26 months of treatment. Caregiver burden was assessed using the Assessment of Caregiver Experience with Neuromuscular Disease. We also assessed motor function using the Hammersmith Functional Motor Scale—Expanded (HFMSE) and the Revised Upper Limb Module score.

Results

Twenty‐four patients and their caregivers were included. The median age of patients at treatment onset was 148.8 (6.8 to 269.4) months. A significant improvement was observed in psychosocial health in proxy‐reported PedsQL ( P = .023). However, the physical health scores of the PedsQL GCS and About my neuromuscular disorder subscores of the PedsQL NMM did not change, although there was a significant increase in HFMSE scores. Regarding the caregiver burden, the financial burden was reduced, whereas time burden increased. A higher HFMSE score was associated with better self‐reported PedsQL GCS total scores ( P < .001).

Discussion

Our results provide insights into the multifaceted implications of disease‐modifying therapies for SMA through patient‐reported outcome measures (PROMs). PROMs should be taken into consideration to assess the clinical significance of the functional changes identified by clinician‐reported scales.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caregiver BurdenMuscular Atrophy, SpinalChildHumansInfantQuality of LifeClinical RelevanceOligonucleotides

Stichwörter der Autor:innen

caregiver burdenhealth-related quality of lifenusinersenpatient-reported outcomespinal muscular atrophy

Substanzen

nusinersenOligonucleotides

Autor:innen und Institutionen

  • Department of Pediatrics, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea.
  • Department of Rehabilitation Medicine, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea.
  • Department of Neurology, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea.
  • Department of Pediatrics, Korea University Ansan Hospital, Seoul, South Korea.
  • Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Pediatrics, Kyungpook National University Children's Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.

ORCID-Profile: Yun Jeong Lee, Jong-Mok Lee

Förderung

  • Biogen

Zitieren

APA

Lee, Y. J., Kim, A. R., Lee, J. M., Shim, Y. K., Cho, J. S., Ryu, H. W., Kwon, S., & Chae, J. H. (2023). Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months. Muscle & Nerve. https://doi.org/10.1002/mus.27950

Vancouver

Lee YJ, Kim AR, Lee JM, Shim YK, Cho JS, Ryu HW, et al. Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months. Muscle & Nerve. 2023. doi:10.1002/mus.27950

BibTeX
@article{Lee2023,
  author = {Lee, Yun Jeong and Kim, Ae Ryoung and Lee, Jong-Mok and Shim, Young Kyu and Cho, Jae So and Ryu, Hye Won and Kwon, Soonhak and Chae, Jong-Hee},
  title = {Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months},
  journal = {Muscle & Nerve},
  year = {2023},
  doi = {10.1002/mus.27950}
}
Kostenlos starten →